Boiron SA (BOI) - Total Liabilities
Based on the latest financial reports, Boiron SA (BOI) has total liabilities worth €210.03 Million EUR (≈ $245.55 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Boiron SA to track the company's year-over-year net asset growth rate.
Boiron SA - Total Liabilities Trend (2001–2025)
This chart illustrates how Boiron SA's total liabilities have evolved over time, based on quarterly financial data. See Boiron SA free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Boiron SA Competitors by Total Liabilities
The table below lists competitors of Boiron SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Sinovatio Technology Co Ltd Class A
SHE:002912
|
China | CN¥337.24 Million |
|
Zenitron Corp
TW:3028
|
Taiwan | NT$15.51 Billion |
|
Shanghai Lili & Beauty Cosmetics Co Ltd
SHG:605136
|
China | CN¥155.82 Million |
|
Mahindra Holidays & Resorts India Limited
NSE:MHRIL
|
India | Rs102.45 Billion |
|
Jiangsu Yida Chemical Co Ltd Class A
SHE:300721
|
China | CN¥1.48 Billion |
|
Thor Explorations Ltd.
V:THX
|
Canada | CA$29.22 Million |
|
Cantor Equity Partners IV, Inc. Class A Ordinary Shares
NASDAQ:CEPF
|
USA | $265.50K |
|
Jiangxi Huawu Brake Co Ltd
SHE:300095
|
China | CN¥1.36 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Boiron SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BOI stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Boiron SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Boiron SA (2001–2025)
The table below shows the annual total liabilities of Boiron SA from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €210.03 Million ≈ $245.55 Million |
+6.00% |
| 2024-12-31 | €198.15 Million ≈ $231.66 Million |
-0.28% |
| 2023-12-31 | €198.70 Million ≈ $232.30 Million |
-14.41% |
| 2022-12-31 | €232.15 Million ≈ $271.40 Million |
-2.84% |
| 2021-12-31 | €238.93 Million ≈ $279.33 Million |
-12.37% |
| 2020-12-31 | €272.65 Million ≈ $318.76 Million |
+5.34% |
| 2019-12-31 | €258.82 Million ≈ $302.59 Million |
-7.90% |
| 2018-12-31 | €281.03 Million ≈ $328.56 Million |
-0.66% |
| 2017-12-31 | €282.91 Million ≈ $330.76 Million |
-0.88% |
| 2016-12-31 | €285.44 Million ≈ $333.70 Million |
+2.16% |
| 2015-12-31 | €279.40 Million ≈ $326.65 Million |
-3.54% |
| 2014-12-31 | €289.67 Million ≈ $338.65 Million |
+5.06% |
| 2013-12-31 | €275.73 Million ≈ $322.36 Million |
+22.48% |
| 2012-12-31 | €225.12 Million ≈ $263.19 Million |
+2.82% |
| 2011-12-31 | €218.96 Million ≈ $255.98 Million |
+2.08% |
| 2010-12-31 | €214.50 Million ≈ $250.77 Million |
+2.80% |
| 2009-12-31 | €208.66 Million ≈ $243.94 Million |
+8.76% |
| 2008-12-31 | €191.86 Million ≈ $224.30 Million |
+7.51% |
| 2007-12-31 | €178.45 Million ≈ $208.62 Million |
-1.94% |
| 2006-12-31 | €181.97 Million ≈ $212.74 Million |
-7.80% |
| 2005-12-31 | €197.37 Million ≈ $230.75 Million |
+55.50% |
| 2004-12-31 | €126.93 Million ≈ $148.39 Million |
+28.94% |
| 2003-12-31 | €98.44 Million ≈ $115.09 Million |
+2.27% |
| 2002-12-31 | €96.26 Million ≈ $112.54 Million |
+11.04% |
| 2001-12-31 | €86.69 Million ≈ $101.35 Million |
-- |
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more